Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer.

Benelli R, Barboro P, Costa D, Astigiano S, Barbieri O, Capaia M, Poggi A, Ferrari N.

Int J Mol Sci. 2019 Dec 3;20(23). pii: E6091. doi: 10.3390/ijms20236091.

2.

Human Gut-Associated Natural Killer Cells in Health and Disease.

Poggi A, Benelli R, Venè R, Costa D, Ferrari N, Tosetti F, Zocchi MR.

Front Immunol. 2019 May 3;10:961. doi: 10.3389/fimmu.2019.00961. eCollection 2019. Review.

3.

Anthropometric and glucometabolic changes in an aged mouse model of lipocalin-2 overexpression.

Principi E, Buschiazzo A, Papait A, Castagnola P, Costa D, Pece R, Maric I, Scussolini M, Marini C, Sambuceti G, Strollo F, Tavella S.

Int J Obes (Lond). 2019 Jan;43(1):189-201. doi: 10.1038/s41366-018-0171-5. Epub 2018 Aug 6.

PMID:
30082752
4.

Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.

Costa D, Venè R, Benelli R, Romairone E, Scabini S, Catellani S, Rebesco B, Mastracci L, Grillo F, Minghelli S, Loiacono F, Zocchi MR, Poggi A.

Front Immunol. 2018 May 29;9:1150. doi: 10.3389/fimmu.2018.01150. eCollection 2018.

5.

Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.

Zocchi MR, Costa D, Venè R, Tosetti F, Ferrari N, Minghelli S, Benelli R, Scabini S, Romairone E, Catellani S, Profumo A, Poggi A.

Oncoimmunology. 2017 Jan 6;6(3):e1278099. doi: 10.1080/2162402X.2016.1278099. eCollection 2017.

6.

The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells.

Penna I, Gigoni A, Costa D, Vella S, Russo D, Poggi A, Villa F, Brizzolara A, Canale C, Mescola A, Daga A, Russo C, Nizzari M, Florio T, Menichini P, Pagano A.

Oncotarget. 2017 Jan 31;8(5):8189-8205. doi: 10.18632/oncotarget.14138.

7.

LCN2 overexpression in bone enhances the hematopoietic compartment via modulation of the bone marrow microenvironment.

Costa D, Principi E, Lazzarini E, Descalzi F, Cancedda R, Castagnola P, Tavella S.

J Cell Physiol. 2017 Nov;232(11):3077-3087. doi: 10.1002/jcp.25755. Epub 2017 Feb 21.

PMID:
28004388
8.

Down-regulation of 21A Alu RNA as a tool to boost proliferation maintaining the tissue regeneration potential of progenitor cells.

Gigoni A, Costa D, Gaetani M, Tasso R, Villa F, Florio T, Pagano A.

Cell Cycle. 2016 Sep 16;15(18):2420-30. doi: 10.1080/15384101.2016.1181242. Epub 2016 Aug 5.

9.

ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing.

Zocchi MR, Camodeca C, Nuti E, Rossello A, Venè R, Tosetti F, Dapino I, Costa D, Musso A, Poggi A.

Oncoimmunology. 2015 Dec 29;5(5):e1123367. doi: 10.1080/2162402X.2015.1123367. eCollection 2016 May.

10.

Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA.

Costa D, Gigoni A, Würth R, Cancedda R, Florio T, Pagano A.

Cancer Cell Int. 2014 Jul 2;14:59. doi: 10.1186/1475-2867-14-59. eCollection 2014.

11.

Novel ncRNAs transcribed by Pol III and elucidation of their functional relevance by biophysical approaches.

Gavazzo P, Vassalli M, Costa D, Pagano A.

Front Cell Neurosci. 2013 Nov 7;7:203. doi: 10.3389/fncel.2013.00203. Review.

12.

Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone.

Costa D, Lazzarini E, Canciani B, Giuliani A, Spanò R, Marozzi K, Manescu A, Cancedda R, Tavella S.

J Cell Physiol. 2013 Nov;228(11):2210-21. doi: 10.1002/jcp.24391.

PMID:
23606520
13.

A novel snRNA-like transcript affects amyloidogenesis and cell cycle progression through perturbation of Fe65L1 (APBB2) alternative splicing.

Penna I, Vassallo I, Nizzari M, Russo D, Costa D, Menichini P, Poggi A, Russo C, Dieci G, Florio T, Cancedda R, Pagano A.

Biochim Biophys Acta. 2013 Jun;1833(6):1511-26. doi: 10.1016/j.bbamcr.2013.02.020. Epub 2013 Feb 26.

14.

A novel collection of snRNA-like promoters with tissue-specific transcription properties.

Garritano S, Gigoni A, Costa D, Malatesta P, Florio T, Cancedda R, Pagano A.

Int J Mol Sci. 2012;13(9):11323-32. doi: 10.3390/ijms130911323. Epub 2012 Sep 11.

15.

Bone turnover in wild type and pleiotrophin-transgenic mice housed for three months in the International Space Station (ISS).

Tavella S, Ruggiu A, Giuliani A, Brun F, Canciani B, Manescu A, Marozzi K, Cilli M, Costa D, Liu Y, Piccardi F, Tasso R, Tromba G, Rustichelli F, Cancedda R.

PLoS One. 2012;7(3):e33179. doi: 10.1371/journal.pone.0033179. Epub 2012 Mar 15.

16.

Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone.

Costa D, Biticchi R, Negrini S, Tasso R, Cancedda R, Descalzi F, Pennesi G, Tavella S.

Cytokine. 2010 Jul;51(1):47-52. doi: 10.1016/j.cyto.2010.02.009. Epub 2010 Apr 1.

PMID:
20362461

Supplemental Content

Loading ...
Support Center